No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bendamustine Hydrochloride / adverse effects
-
Cyclophosphamide / adverse effects
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
-
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Substances
-
Bendamustine Hydrochloride
-
obinutuzumab
-
fludarabine
-
Cyclophosphamide